Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
First Claim
Patent Images
1. A nitric oxide-releasing particle comprising:
- a co-condensed silica network comprising methylaminopropyl trimethoxysilane (MAP3) and tetraethyl orthosilicate (TEOS), wherein the MAP3 is distributed throughout the nitric oxide-releasing particle, and wherein the MAP3 comprises N-diazeniumdiolate functionalized MAP3.
3 Assignments
0 Petitions
Accused Products
Abstract
The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
517 Citations
5 Claims
-
1. A nitric oxide-releasing particle comprising:
a co-condensed silica network comprising methylaminopropyl trimethoxysilane (MAP3) and tetraethyl orthosilicate (TEOS), wherein the MAP3 is distributed throughout the nitric oxide-releasing particle, and wherein the MAP3 comprises N-diazeniumdiolate functionalized MAP3. - View Dependent Claims (2, 3, 4, 5)
Specification